Glenmark, Strides Pharma and Cipla recall products in US
The recall has taken place due to manufacturing issues
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cipla
US FDA issues Form 483 to Cipla’s facility in MP
The FDA has censured the drug maker due to unclean equipment and lack of data
Cipla betting big on digitisation and emerging segments
The drugmaker is also bullish on maximising value opportunity in the complex generics in the US market
Cipla Health to acquire Endura Mass From Medinnbelle Herbalcare
The acquisition is in line with Cipla's strategic imperative to augment its wellness portfolio for bringing about a shift from an…
Cipla to invest Rs 26 crores in GoApptiv to raise stake to 22 per cent
Cipla has agreed to acquire an additional stake for nearly Rs 26 crores in digital tech company GoApptiv Private to raise its…
Cipla to acquire 21 per cent stake in Achira Labs for Rs 25 crores
Cipla said the transaction is expected to be completed within 60 days
Cipla, DNDi launch 4-in-1 antiretroviral treatment for young children with HIV in South Africa
The ‘4-in-1’ combination contains an antiretroviral combination that is recommended by the WHO as an alternative first-line…
Cipla adds capacity of captive renewable energy power plant in Maharashtra and Karnataka
The project will support the company’s green energy requirements for its manufacturing units at Kurkumbh and Patalganga and…
Cipla partners with Genes2Me for commercialisation of ‘RT-Direct’ multiplex COVID-19 RT PCR test kit
RNA extraction free kit to deliver results in 45 minutes
A seat at the table: Shaping the healthcare policy landscape
While trade agreements with Australia, the UK, Canada and Bangladesh are nearing completion, and discussions with the EU and…